Evidence map›Paper›PMID 37402225›Full record

ArticleScience signaling2023

Clustering of phosphatase RPTPα promotes Src signaling and the arthritogenic action of synovial fibroblasts.

Sho Sendo, William B Kiosses, Shen Yang, Dennis J Wu, Daniel W K Lee, Lin Liu, Yael Aschner, Allison J Vela, Gregory P Downey, Eugenio Santelli and 1 more

Open access · greenAbstract read
In one paragraph

Article in Science signaling, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Sho SendoDepartment of Medicine, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0002-7193-341X
William B KiossesDepartment of Medicine, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0003-1832-9050
Shen YangDepartment of Medicine, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0002-4983-6787
Dennis J WuDepartment of Medicine, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0002-6021-5607
Daniel W K LeeDepartment of Medicine, University of California San Diego, La Jolla, CA, USA.ORCID 0009-0009-1974-2294
Lin LiuDepartment of Medicine, University of California San Diego, La Jolla, CA, USA.
Yael AschnerDivision of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado, Aurora, CO, USA.ORCID 0000-0002-8246-1083
Allison J VelaDepartment of Medicine, University of California San Diego, La Jolla, CA, USA.
Gregory P DowneyDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, CO, USA.
Eugenio SantelliDepartment of Medicine, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0002-8739-2750
Nunzio BottiniDepartment of Medicine, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0001-9025-7501
University of California San Diego · USCedars-Sinai Medical Center · USLa Jolla Institute for Immunology · USNational Jewish Health · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary FibrosisUH3TR002445 · NCATS · NATIONAL JEWISH HEALTH · PI DOWNEY, GREGORY PAUL, KAMINSKI, NAFTALI · 2019 to 2021
$5.0M
Role of PTPRS in Rheumatoid ArtiritisR01AR066053 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BOTTINI, NUNZIO · 2014 to 2025
$4.0M
Resource-based Center for the study of the joint microenvironment in rheumatology (Overall Application)P30AR073761 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CORR, MARY P · 2018 to 2022
$3.9M
Rheumatic Diseases Research Training GrantT32AR064194 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GARY S FIRESTEIN, Monica Guma · 2013 to 2026
$3.8M
Proteolysis in the Pathogenesis of ARDSR01HL157424 · NHLBI · NATIONAL JEWISH HEALTH · PI DOWNEY, GREGORY PAUL, RADISKY, DEREK C · 2022 to 2025
$2.8M
Checkpoint Function of PTPalpha in Pathological Fibrogenesis in the LungR01HL132950 · NHLBI · NATIONAL JEWISH HEALTH · PI DOWNEY, GREGORY PAUL · 2016 to 2019
$2.0M
Super-resolution confocal microscopeS10OD021831 · OD · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI LEY, KLAUS F. · 2017 to 2017
$566k
Targeting PTPalpha to Prevent Lung FibrosisR21ES023932 · NIEHS · NATIONAL JEWISH HEALTH · PI DOWNEY, GREGORY PAUL · 2014 to 2015
$436k
NCATS NIH HHS UH3 TR002445NHLBI NIH HHS R01 HL132950NHLBI NIH HHS R01 HL157424NIAMS NIH HHS P30 AR073761NIAMS NIH HHS R01 AR066053NIAMS NIH HHS T32 AR064194NIEHS NIH HHS R21 ES023932NIH HHS S10 OD021831
6 · The paper itself

Abstract

Receptor-type protein phosphatase α (RPTPα) promotes fibroblast-dependent arthritis and fibrosis, in part, by enhancing the activation of the kinase SRC. Synovial fibroblasts lining joint tissue mediate inflammation and tissue damage, and their infiltration into adjacent tissues promotes disease progression. RPTPα includes an ectodomain and two intracellular catalytic domains (D1 and D2) and, in cancer cells, undergoes inhibitory homodimerization, which is dependent on a D1 wedge motif. Through single-molecule localization and labeled molecule interaction microscopy of migrating synovial fibroblasts, we investigated the role of RPTPα dimerization in the activation of SRC, the migration of synovial fibroblasts, and joint damage in a mouse model of arthritis. RPTPα clustered with other RPTPα and with SRC molecules in the context of actin-rich structures. A known dimerization-impairing mutation in the wedge motif (P210L/P211L) and the deletion of the D2 domain reduced RPTPα-RPTPα clustering; however, it also unexpectedly reduced RPTPα-SRC association. The same mutations also reduced recruitment of RPTPα to actin-rich structures and inhibited SRC activation and cellular migration. An antibody against the RPTPα ectodomain that prevented the clustering of RPTPα also inhibited RPTPα-SRC association and SRC activation and attenuated fibroblast migration and joint damage in arthritic mice. A catalytically inactivating RPTPα-C469S mutation protected mice from arthritis and reduced SRC activation in synovial fibroblasts. We conclude that RPTPα clustering retains it to actin-rich structures to promote SRC-mediated fibroblast migration and can be modulated through the extracellular domain.

Indexed as

ActinsArthritisAnimalsCluster AnalysisFibroblastsMicePhosphoprotein PhosphatasesProtein Tyrosine PhosphatasesReceptor-Like Protein Tyrosine Phosphatases, Class 4ActinsPhosphoprotein PhosphatasesProtein Tyrosine PhosphatasesPtpra protein, mouseReceptor-Like Protein Tyrosine Phosphatases, Class 4

Identifiers

PMID37402225
PMCPMC10544828
OpenAlexW4383066285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.